“Compounded semaglutide is the same as Ozempic — it's literally the same molecule, just cheaper.”
What the evidence shows
Ozempic and Wegovy are FDA-approved products whose identity, purity, concentration, sterility, and dose accuracy are reviewed and subject to post-market surveillance; compounded semaglutide is not FDA-approved and does not go through that review for safety, effectiveness, or quality. The FDA has also flagged that some compounded products use different salt forms (semaglutide sodium or acetate) that are not the same active ingredient as the approved drug and have not been shown to be equivalent.
What we still don’t know
There is no systematic surveillance of the compounded and grey-market supply, so the true prevalence of mislabeling, contamination, and under- or over-concentration is unknown. For any individual compounded vial, no independent regulator has verified that its contents match the approved drug's identity, purity, or strength.
Why the claim misleads
"Same molecule" describes chemistry only — it says nothing about the manufacturing oversight, sterility, dose accuracy, and accountability that are exactly what differ between the products. In some cases it is not even the same molecule (salt forms), and the FDA has documented adverse events and serious dosing errors tied to compounded semaglutide, including overdoses requiring hospitalization.
Source: FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Graded by The Peptide Era · evidence, not hype